During the past decade, Aichi Cancer Center Hospital conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 20 clinical trials were completed, i.e. on average, 37% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 16 clinical trials were completed. i.e. 59.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aichi Cancer Center Hospital" #1 sponsor was "Pfizer" with 15 trials, followed by "Hoffmann-La Roche" with 9 trials sponsored, "Celgene" with 5 trials sponsored, "Daiichi Sankyo, Inc." with 5 trials sponsored and "Incyte Corporation" with 5 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aichi Cancer Center Hospital" #1 collaborator was "AstraZeneca" with 7 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator, "Daiichi Sankyo, Inc." with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator and "Niigata University Medical & Dental Hospital" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Aichi Cancer Center Hospital" are "Carcinoma, Non-Small-Cell Lung" (6 trials), "Breast Cancer" (5 trials), "Non-small Cell Lung Cancer" (4 trials), "Head and Neck Cancer" (3 trials) and "Metastatic Colorectal Cancer" (3 trials). Many other conditions were trialed in "Aichi Cancer Center Hospital" in a lesser frequency.

Most popular intervention types in "Aichi Cancer Center Hospital" are "Drug" (69 trials), "Radiation" (5 trials), "Device" (3 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Pemetrexed" (6 trials), "Atezolizumab" (5 trials), "Docetaxel" (5 trials) and "Amivantamab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Aichi Cancer Center Hospital" are 73 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Aichi Cancer Center Hospital". undefined are not yet recruiting, 17 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Aichi Cancer Center Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Aichi Cancer Center Hospital, 18 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Aichi Cancer Center Hospital has several departments that took part in Clinical trials: "Aichi Cancer Center" - 24 trials, "Aichi Cancer Center Hospital" - 16 trials, "Aichi Children's Health and Medical Center" - 11 trials, "Aichi Cancer Center Hospital, Breast Oncology" - 6 trials, "Aichi Cancer Center Hospital ( Site 0803)" - 2 trials, "Hiramitsu Heart Clinic" - 2 trials